U.K. Pharmaceuticals & Biotech Leverage Leaders

Oxford Nanopore Technologies

Market Cap: UK£1.7b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.